Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-13

Clinical Trial Update: Frontier Registry II Bifurcation Stent System Registry [Phase 4]

View source ↗

Summary

The Frontier Registry II Bifurcation Stent System Phase 4 trial has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Artery Disease | Phase 4 | Status: WITHDRAWN